Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Arrhythmogenic right ventricular cardiomyopathy (ARVC) (mmu05412)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Actb
KLA  ATP  ATP+KLA
 BC016624 cDNA clone IMAGE:4501052 [BC016624] KLA 1.20 1.20 1.19 1.73 1.83 2.52 1.70
ATP 1.04 1.01 1.03 .92 1.07 .66 .91
KLA/ATP 1.34 1.40 1.69 1.28 1.27 1.19 1.06
Actb
KLA  ATP  ATP+KLA
 NM_007393 actin, beta, cytoplasmic (Actb), mRNA [NM_007393] KLA 1.58 1.64 1.59 2.02 2.03 3.04 1.75
ATP 1.00 .95 1.26 1.18 1.33 .86 .91
KLA/ATP 1.52 1.75 2.42 1.92 2.17 1.54 1.28
Actg1
KLA  ATP  ATP+KLA
 NM_009609 actin, gamma, cytoplasmic 1 (Actg1), mRNA [NM_009609] KLA 1.02 1.03 1.34 1.07 1.49 1.58 .71
ATP 1.07 1.24 .76 .76 .63 .46 .78
KLA/ATP 1.20 1.30 .75 .82 .60 .53 .55
Actn1
KLA  ATP  ATP+KLA
 NM_134156 actinin, alpha 1 (Actn1), mRNA [NM_134156] KLA 1.33 1.42 1.46 1.16 1.18 .69 .54
ATP 1.06 1.13 .67 1.15 .95 .99 1.46
KLA/ATP 1.66 1.64 .81 1.55 .82 .78 .76
Actn2
KLA  ATP  ATP+KLA
 NM_033268 actinin alpha 2 (Actn2), mRNA [NM_033268] KLA 1.03 .94 1.02 1.05 1.02 1.06 1.11
ATP 1.04 .98 1.07 .99 1.10 1.03 1.02
KLA/ATP 1.06 1.03 .99 1.08 1.01 1.05 .98
Actn3
KLA  ATP  ATP+KLA
 NM_013456 actinin alpha 3 (Actn3), mRNA [NM_013456] KLA .97 .98 .98 .94 1.03 .96 1.07
ATP .95 .95 1.02 .98 .94 .95 1.01
KLA/ATP 1.05 1.03 .94 1.03 1.03 1.00 .95
Actn4
KLA  ATP  ATP+KLA
 NM_021895 actinin alpha 4 (Actn4), mRNA [NM_021895] KLA .78 .77 .75 .74 .58 .51 .65
ATP 1.03 1.03 1.21 1.14 1.50 1.30 1.09
KLA/ATP .78 .85 .96 .84 1.09 1.12 .97
AK043675
KLA  ATP  ATP+KLA
 AK043675 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830019B06 product:unclassifiable, full insert sequence. [AK043675] KLA 1.07 1.05 1.00 .98 1.05 1.02 1.00
ATP .92 1.07 .99 .93 1.01 1.01 1.02
KLA/ATP .96 .93 1.08 1.00 .94 .97 1.02
Atp2a2
KLA  ATP  ATP+KLA
 NM_001110140 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (Atp2a2), transcript variant 1, mRNA [NM_001110140] KLA .95 1.07 .96 .84 1.17 1.16 1.53
ATP 1.16 1.27 .80 1.14 1.10 1.23 1.35
KLA/ATP 1.14 1.10 .54 1.15 .91 1.10 1.01
Atp2a2
KLA  ATP  ATP+KLA
 NM_009722 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (Atp2a2), transcript variant 2, mRNA [NM_009722] KLA .90 .90 .99 .96 1.28 1.09 1.29
ATP 1.09 1.12 .94 1.19 1.47 1.36 .98
KLA/ATP .98 .95 .72 1.06 1.44 1.30 .88
Cacna1d
KLA  ATP  ATP+KLA
 NM_001083616 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 2, mRNA [NM_001083616] KLA 1.57 1.58 2.50 3.62 4.55 2.93 .99
ATP 1.12 .99 .97 .94 .75 1.71 1.48
KLA/ATP 1.47 1.51 1.82 1.56 1.67 2.93 4.60
Cacna1d
KLA  ATP  ATP+KLA
 NM_028981 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 1, mRNA [NM_028981] KLA 1.20 1.26 1.43 1.62 2.07 1.66 1.00
ATP 1.03 1.03 .97 .97 .93 1.20 1.26
KLA/ATP 1.16 1.12 1.10 1.14 1.08 1.44 2.56
Cacna1f
KLA  ATP  ATP+KLA
 NM_019582 calcium channel, voltage-dependent, alpha 1F subunit (Cacna1f), mRNA [NM_019582] KLA 1.03 .98 1.05 1.06 1.00 1.02 1.01
ATP 1.05 1.05 .95 .98 .97 .96 1.01
KLA/ATP 1.01 1.03 .94 1.01 1.01 1.00 .99
Cacna1s
KLA  ATP  ATP+KLA
 NM_001081023 calcium channel, voltage-dependent, L type, alpha 1S subunit (Cacna1s), mRNA [NM_001081023] KLA 1.03 1.01 .96 1.06 1.00 1.00 1.05
ATP 1.01 .98 1.02 1.02 1.05 1.07 1.05
KLA/ATP .99 1.05 1.02 1.05 1.03 1.05 1.00
Cacna2d1
KLA  ATP  ATP+KLA
 AK046959 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930007O16 product:calcium channel, voltage-dependent, alpha2/delta subunit 1, full insert sequence. [AK046959] KLA 1.04 1.01 .94 .95 1.04 1.05 1.05
ATP 1.06 .98 .99 1.04 1.02 1.00 1.05
KLA/ATP 1.04 1.01 .99 1.04 .99 1.01 .99
Cacna2d1
KLA  ATP  ATP+KLA
 NM_009784 calcium channel, voltage-dependent, alpha2/delta subunit 1 (Cacna2d1), transcript variant e, mRNA [NM_009784] KLA 1.02 1.02 1.02 1.00 1.03 1.01 1.02
ATP .99 .97 1.07 1.01 .99 .97 1.00
KLA/ATP 1.03 .99 1.01 1.04 1.03 1.01 .92
Cacna2d2
KLA  ATP  ATP+KLA
 NM_020263 calcium channel, voltage-dependent, alpha 2/delta subunit 2 (Cacna2d2), mRNA [NM_020263] KLA 1.03 1.04 1.03 .99 1.03 .93 .93
ATP 1.01 1.06 1.06 1.15 1.03 .99 .93
KLA/ATP 1.04 1.01 1.10 1.13 1.11 .97 .89
Cacna2d3
KLA  ATP  ATP+KLA
 NM_009785 calcium channel, voltage-dependent, alpha2/delta subunit 3 (Cacna2d3), mRNA [NM_009785] KLA 1.00 .98 1.07 .96 .99 .99 .99
ATP .99 .97 1.10 .99 1.00 .89 .97
KLA/ATP .95 1.04 1.00 .95 1.02 .99 .98
Cacna2d4
KLA  ATP  ATP+KLA
 AK030723 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730412N02 product:hypothetical von Willebrand factor type A domain containing protein, full insert sequence. [AK030723] KLA .97 1.02 1.04 1.01 1.00 1.03 1.02
ATP 1.01 .93 1.03 1.01 .99 .99 1.01
KLA/ATP 1.03 .95 .87 .96 1.03 .97 1.05
Cacnb1
KLA  ATP  ATP+KLA
 NM_031173 calcium channel, voltage-dependent, beta 1 subunit (Cacnb1), transcript variant variant 1, mRNA [NM_031173] KLA 1.35 1.26 1.13 1.51 1.54 1.69 2.10
ATP 1.01 1.09 1.16 1.23 1.39 1.61 1.34
KLA/ATP 1.20 1.34 1.81 1.43 1.62 1.50 2.03
Cacnb2
KLA  ATP  ATP+KLA
 AK143332 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330008B16 product:calcium channel, voltage-dependent, beta 2 subunit, full insert sequence [AK143332] KLA 1.18 1.19 1.17 1.05 1.03 1.03 1.03
ATP .97 .91 1.02 1.07 .95 1.07 1.03
KLA/ATP 1.20 1.29 1.16 1.09 1.02 1.05 1.03
Cacnb2
KLA  ATP  ATP+KLA
 NM_023116 calcium channel, voltage-dependent, beta 2 subunit (Cacnb2), mRNA [NM_023116] KLA 1.23 1.15 1.47 1.25 1.02 1.02 1.05
ATP 1.00 1.01 .99 .99 1.02 1.01 1.01
KLA/ATP 1.21 1.27 1.12 1.24 .96 .98 1.02
Cacnb3
KLA  ATP  ATP+KLA
 NM_007581 calcium channel, voltage-dependent, beta 3 subunit (Cacnb3), transcript variant 1, mRNA [NM_007581] KLA 5.88 5.27 7.39 5.78 4.94 2.13 1.26
ATP 1.03 1.02 1.22 1.37 2.49 2.75 1.61
KLA/ATP 5.92 6.99 6.43 6.99 5.42 3.70 2.61
Cacnb4
KLA  ATP  ATP+KLA
 NM_001037099 calcium channel, voltage-dependent, beta 4 subunit (Cacnb4), transcript variant 1, mRNA [NM_001037099] KLA 1.07 1.11 1.17 1.11 1.15 1.13 1.07
ATP 1.00 1.00 1.03 1.06 1.21 1.17 1.50
KLA/ATP 1.13 1.12 1.15 1.16 1.35 1.69 1.32
Cacng1
KLA  ATP  ATP+KLA
 NM_007582 calcium channel, voltage-dependent, gamma subunit 1 (Cacng1), mRNA [NM_007582] KLA .98 .93 .99 .99 .96 .99 1.04
ATP 1.07 1.40 2.33 2.01 1.57 1.10 1.08
KLA/ATP 1.02 .94 .98 1.16 1.07 .98 1.05
Cacng2
KLA  ATP  ATP+KLA
 AK047238 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930041E13 product:hypothetical protein, full insert sequence [AK047238] KLA 1.18 1.18 1.12 1.11 1.10 1.17 1.35
ATP 1.03 .98 1.09 1.04 1.07 1.06 1.00
KLA/ATP 1.15 1.15 1.25 1.15 1.12 1.07 1.19
Cacng2
KLA  ATP  ATP+KLA
 NM_007583 calcium channel, voltage-dependent, gamma subunit 2 (Cacng2), mRNA [NM_007583] KLA 1.00 1.08 1.08 .95 1.07 1.09 1.03
ATP 1.04 1.05 1.05 1.04 1.00 1.02 .99
KLA/ATP 1.00 .98 1.02 1.09 1.06 1.07 1.03
Cacng3
KLA  ATP  ATP+KLA
 NM_019430 calcium channel, voltage-dependent, gamma subunit 3 (Cacng3), mRNA [NM_019430] KLA 1.07 1.09 1.00 .97 1.01 .94 .89
ATP 1.06 1.11 1.07 1.00 .98 .99 .97
KLA/ATP 1.07 1.06 1.03 .94 1.00 .99 .95
Cacng4
KLA  ATP  ATP+KLA
 AJ272045 mRNA for calcium channel gamma 4 subunit (CACNG4 gene) [AJ272045] KLA .99 .95 1.01 1.02 .98 1.09 .92
ATP .96 1.09 1.00 .95 .97 1.06 .95
KLA/ATP .97 1.01 1.04 .97 1.00 .96 .98
Cacng5
KLA  ATP  ATP+KLA
 NM_080644 calcium channel, voltage-dependent, gamma subunit 5 (Cacng5), mRNA [NM_080644] KLA .98 .99 .91 .98 1.02 .98 .98
ATP .96 1.02 .99 .99 1.05 1.04 .95
KLA/ATP .95 1.01 1.07 .99 1.02 .95 .99
Cacng6
KLA  ATP  ATP+KLA
 NM_133183 calcium channel, voltage-dependent, gamma subunit 6 (Cacng6), mRNA [NM_133183] KLA .95 .95 .94 1.03 .94 1.09 1.14
ATP 1.00 1.05 .95 1.05 .94 .93 .99
KLA/ATP 1.02 .98 .92 .97 1.02 .96 1.05
Cacng7
KLA  ATP  ATP+KLA
 NM_133189 calcium channel, voltage-dependent, gamma subunit 7 (Cacng7), mRNA [NM_133189] KLA 1.01 1.04 .98 1.01 1.00 1.05 1.02
ATP 1.05 1.03 .99 1.00 .98 .95 .98
KLA/ATP 1.00 .98 1.07 .99 .97 1.03 1.01
Cacng8
KLA  ATP  ATP+KLA
 NM_133190 calcium channel, voltage-dependent, gamma subunit 8 (Cacng8), mRNA [NM_133190] KLA 1.17 1.16 1.20 1.31 1.16 1.13 1.09
ATP .98 1.09 1.06 1.06 1.03 1.18 .99
KLA/ATP 1.27 1.35 1.29 1.09 1.04 1.06 1.19
Cdh2
KLA  ATP  ATP+KLA
 NM_007664 cadherin 2 (Cdh2), mRNA [NM_007664] KLA 1.05 1.01 .97 .91 .98 1.10 1.01
ATP 1.01 .95 .97 .98 1.00 1.00 1.02
KLA/ATP .98 1.00 .98 1.03 .96 1.00 1.02
Ctnna1
KLA  ATP  ATP+KLA
 AK008121 adult male small intestine cDNA, RIKEN full-length enriched library, clone:2010005H04 product:unclassifiable, full insert sequence. [AK008121] KLA .82 .76 .72 .81 .94 .74 .80
ATP 1.08 1.01 .51 .57 2.45 1.25 .95
KLA/ATP .91 .82 .76 .58 1.58 1.01 .92
Ctnna1
KLA  ATP  ATP+KLA
 NM_009818 catenin (cadherin associated protein), alpha 1 (Ctnna1), mRNA [NM_009818] KLA .97 .91 1.06 .84 .75 .52 .56
ATP 1.09 1.14 1.00 .86 .80 .98 .83
KLA/ATP 1.02 1.07 .90 .80 .66 .59 .57
Ctnna2
KLA  ATP  ATP+KLA
 AK035033 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430076K22 product:hypothetical Vinculin and alpha-catenin containing protein, full insert sequence [AK035033] KLA 1.05 1.11 1.12 1.05 1.02 1.04 1.19
ATP .99 .97 1.00 1.05 1.02 1.05 1.03
KLA/ATP 1.11 1.06 1.01 1.12 1.06 1.02 1.03
Ctnna3
KLA  ATP  ATP+KLA
 AK029664 adult male testis cDNA, RIKEN full-length enriched library, clone:4930438F12 product:unclassifiable, full insert sequence. [AK029664] KLA 1.03 1.06 .99 1.05 .95 1.01 1.04
ATP 1.03 1.05 1.02 1.04 .99 1.03 1.05
KLA/ATP 1.01 1.00 .99 1.01 1.00 .98 1.05
Ctnna3
KLA  ATP  ATP+KLA
 NM_177612 catenin (cadherin associated protein), alpha 3 (Ctnna3), mRNA [NM_177612] KLA 1.01 1.06 .98 1.04 1.03 1.04 1.07
ATP .96 1.02 .94 1.11 1.02 1.09 .91
KLA/ATP 1.01 .94 .94 1.10 1.10 1.04 1.04
Ctnnb1
KLA  ATP  ATP+KLA
 AK020013 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830416C23 product:catenin beta, full insert sequence. [AK020013] KLA 1.06 1.15 1.00 1.06 1.27 1.14 1.03
ATP .85 .57 1.74 3.36 4.13 2.19 1.55
KLA/ATP 1.12 .87 2.47 3.61 3.79 2.21 2.06
Ctnnb1
KLA  ATP  ATP+KLA
 NM_007614 catenin (cadherin associated protein), beta 1 (Ctnnb1), mRNA [NM_007614] KLA 1.02 1.07 1.13 1.03 1.04 .93 .96
ATP 1.12 1.14 .75 .77 .73 .72 1.52
KLA/ATP 1.18 1.17 .77 .85 .60 .59 1.35
Dag1
KLA  ATP  ATP+KLA
 NM_010017 dystroglycan 1 (Dag1), mRNA [NM_010017] KLA .74 .75 .67 .59 .62 .61 .66
ATP 1.16 1.24 .87 1.18 1.00 .91 1.17
KLA/ATP .88 .84 .53 .70 .75 .96 .90
Des
KLA  ATP  ATP+KLA
 NM_010043 desmin (Des), mRNA [NM_010043] KLA .99 1.01 1.01 1.02 1.02 1.03 1.01
ATP 1.00 1.00 1.01 1.02 .98 1.01 .99
KLA/ATP 1.02 1.02 1.10 1.01 1.00 1.01 1.01
Dmd
KLA  ATP  ATP+KLA
 AK044536 adult retina cDNA, RIKEN full-length enriched library, clone:A930019F21 product:DYSTROPHIN homolog [Mus musculus], full insert sequence. [AK044536] KLA 1.02 .99 .98 1.00 .94 1.06 1.02
ATP .94 1.06 .95 .96 1.00 1.00 1.02
KLA/ATP .98 1.07 1.01 .86 .96 1.02 1.04
Dmd
KLA  ATP  ATP+KLA
 NM_007868 dystrophin, muscular dystrophy (Dmd), mRNA [NM_007868] KLA 1.00 .99 1.00 1.02 1.02 1.00 1.03
ATP .99 1.03 1.02 1.03 1.00 1.01 1.00
KLA/ATP 1.03 1.03 1.01 1.01 1.03 1.04 .99
Dsc2
KLA  ATP  ATP+KLA
 NM_013505 desmocollin 2 (Dsc2), mRNA [NM_013505] KLA 1.00 1.02 .97 1.03 1.00 1.02 1.00
ATP 1.00 1.00 1.00 1.02 1.01 1.04 .98
KLA/ATP 1.02 1.03 1.00 .98 .99 1.00 .95
Dsg2
KLA  ATP  ATP+KLA
 NM_007883 desmoglein 2 (Dsg2), mRNA [NM_007883] KLA 1.02 1.03 1.02 1.02 1.00 1.01 .99
ATP 1.01 1.05 1.02 .96 1.00 1.02 1.02
KLA/ATP 1.01 1.00 1.05 1.00 .98 .98 1.01
Dsp
KLA  ATP  ATP+KLA
 XM_621314 gb|PREDICTED: Mus musculus desmoplakin, transcript variant 1 (Dsp), mRNA [XM_621314] KLA .95 1.02 1.03 1.02 .99 .98 1.03
ATP .98 .98 1.07 1.00 .96 .99 1.01
KLA/ATP 1.05 1.02 1.00 1.06 1.01 1.02 .99
Emd
KLA  ATP  ATP+KLA
 NM_007927 emerin (Emd), mRNA [NM_007927] KLA 1.03 1.19 .93 1.06 1.06 1.45 .93
ATP .98 1.14 .96 .91 .91 1.19 .69
KLA/ATP 1.07 1.17 1.08 1.13 1.07 1.07 1.04
Gja1
KLA  ATP  ATP+KLA
 NM_010288 gap junction protein, alpha 1 (Gja1), mRNA [NM_010288] KLA 3.34 3.26 3.59 3.08 2.26 1.50 .90
ATP 1.01 1.08 1.38 1.42 3.24 16.32 1.56
KLA/ATP 3.47 3.78 3.71 3.44 2.75 4.11 1.77
Itga1
KLA  ATP  ATP+KLA
 NM_001033228 integrin alpha 1 (Itga1), mRNA [NM_001033228] KLA 1.08 1.09 1.13 1.05 1.04 .99 1.01
ATP 1.02 .97 1.03 1.03 1.09 1.43 3.50
KLA/ATP 1.06 1.04 1.07 1.00 1.06 1.12 1.33
Itga10
KLA  ATP  ATP+KLA
 NM_001081053 integrin, alpha 10 (Itga10), mRNA [NM_001081053] KLA .98 1.00 1.00 1.04 1.04 .96 1.00
ATP 1.05 1.00 .97 .98 .95 .96 .97
KLA/ATP 1.04 .98 .92 .96 .95 .97 1.00
Itga11
KLA  ATP  ATP+KLA
 NM_176922 integrin, alpha 11 (Itga11), mRNA [NM_176922] KLA .95 .92 .90 .97 .93 .93 .96
ATP .97 .92 .98 .95 .90 .94 .95
KLA/ATP .86 .94 1.01 .93 .97 .94 .88
Itga2
KLA  ATP  ATP+KLA
 NM_008396 integrin alpha 2 (Itga2), mRNA [NM_008396] KLA 1.03 1.00 .98 1.01 .97 .96 1.00
ATP 1.05 .99 .93 1.02 1.04 1.03 .97
KLA/ATP .98 1.06 1.03 1.00 1.00 1.01 1.01
Itga2b
KLA  ATP  ATP+KLA
 NM_010575 integrin alpha 2b (Itga2b), mRNA [NM_010575] KLA 1.01 1.00 .98 1.04 1.01 1.04 1.18
ATP 1.01 .98 .95 1.02 .96 1.13 1.08
KLA/ATP 1.04 1.02 1.02 .95 1.05 1.53 1.23
Itga3
KLA  ATP  ATP+KLA
 NM_013565 integrin alpha 3 (Itga3), mRNA [NM_013565] KLA 1.06 1.09 1.10 1.17 1.19 1.29 1.41
ATP .99 .99 1.05 1.12 1.20 1.25 1.33
KLA/ATP 1.08 1.14 1.15 1.27 1.28 1.20 1.39
Itga4
KLA  ATP  ATP+KLA
 NM_010576 integrin alpha 4 (Itga4), mRNA [NM_010576] KLA 4.65 4.83 4.47 3.76 2.93 1.65 1.01
ATP 1.10 1.12 1.17 1.08 .86 .75 .36
KLA/ATP 4.82 5.02 4.43 3.69 2.11 1.13 .79
Itga5
KLA  ATP  ATP+KLA
 NM_010577 integrin alpha 5 (fibronectin receptor alpha) (Itga5), mRNA [NM_010577] KLA 2.63 3.04 2.81 2.47 4.61 5.45 4.90
ATP 1.13 1.62 .74 2.21 1.31 1.93 2.84
KLA/ATP 3.55 3.84 1.15 3.03 1.11 2.81 10.42
Itga6
KLA  ATP  ATP+KLA
 BC024571 integrin alpha 6, mRNA (cDNA clone IMAGE:5036677). [BC024571] KLA .44 .44 .37 .28 .25 .29 .34
ATP .96 1.01 .90 .58 .35 .11 .22
KLA/ATP .44 .41 .34 .23 .15 .09 .08
Itga6
KLA  ATP  ATP+KLA
 NM_008397 integrin alpha 6 (Itga6), mRNA [NM_008397] KLA .57 .58 .51 .45 .43 .44 .47
ATP 1.05 1.12 .86 .90 .57 .27 .36
KLA/ATP .64 .67 .50 .57 .39 .29 .26
Itga7
KLA  ATP  ATP+KLA
 L23423 gb|Mouse (BALB/c) alpha-7 integrin mRNA, complete cds. [L23423] KLA .96 1.03 1.00 1.07 1.02 1.07 1.14
ATP 1.00 1.00 1.04 1.88 2.09 1.34 1.16
KLA/ATP 1.04 .97 1.07 1.79 1.68 1.39 1.11
Itga7
KLA  ATP  ATP+KLA
 NM_008398 integrin alpha 7 (Itga7), mRNA [NM_008398] KLA .98 .95 .98 1.01 1.04 1.03 .98
ATP 1.00 1.02 1.06 1.75 1.92 1.20 1.02
KLA/ATP 1.03 1.07 1.06 1.48 1.58 1.23 1.05
Itga8
KLA  ATP  ATP+KLA
 NM_001001309 integrin alpha 8 (Itga8), mRNA [NM_001001309] KLA .80 .81 .79 .75 .63 .61 .44
ATP .98 1.04 1.06 .94 .79 .61 .50
KLA/ATP .79 .81 .81 .71 .70 .65 .48
Itgav
KLA  ATP  ATP+KLA
 AK052514 13 days embryo lung cDNA, RIKEN full-length enriched library, clone:D430040G12 product:hypothetical protein, full insert sequence. [AK052514] KLA 1.04 .93 1.05 1.02 1.01 .93 1.03
ATP 1.05 1.04 1.13 1.12 1.12 .91 1.02
KLA/ATP 1.08 .97 1.02 .95 1.01 .96 1.05
Itgav
KLA  ATP  ATP+KLA
 AK171739 activated spleen cDNA, RIKEN full-length enriched library, clone:F830008B15 product:unclassifiable, full insert sequence. [AK171739] KLA 1.04 .97 1.06 .95 1.15 .89 1.11
ATP 1.41 1.54 1.64 2.24 2.74 1.24 1.18
KLA/ATP 1.09 1.07 1.03 1.01 1.72 1.24 1.10
Itgav
KLA  ATP  ATP+KLA
 NM_008402 integrin alpha V (Itgav), mRNA [NM_008402] KLA 4.00 3.99 3.28 2.24 1.57 .95 1.13
ATP 1.14 1.22 1.13 1.39 2.22 2.47 1.70
KLA/ATP 4.59 4.61 2.48 2.44 1.60 1.88 2.56
Itgb1
KLA  ATP  ATP+KLA
 NM_010578 integrin beta 1 (fibronectin receptor beta) (Itgb1), mRNA [NM_010578] KLA 1.05 1.09 1.13 .92 1.01 .93 .88
ATP 1.14 1.30 .92 1.07 1.04 .83 .70
KLA/ATP 1.26 1.30 .87 1.02 .66 .65 .62
Itgb1
KLA  ATP  ATP+KLA
 U37029 integrin beta1D mRNA, partial cds. [U37029] KLA .93 .95 .96 1.01 .97 1.01 .98
ATP 1.05 .99 .99 1.03 1.03 .97 .94
KLA/ATP .99 .98 1.04 .97 1.02 1.01 .99
Itgb3
KLA  ATP  ATP+KLA
 AF026509 integrin beta3 subunit mRNA, complete cds. [AF026509] KLA 2.38 2.64 2.65 3.15 4.02 4.46 2.83
ATP 1.21 1.17 1.25 1.62 2.33 3.09 4.78
KLA/ATP 2.48 2.63 3.39 3.72 4.30 4.71 6.79
Itgb3
KLA  ATP  ATP+KLA
 NM_016780 integrin beta 3 (Itgb3), mRNA [NM_016780] KLA .50 .51 .52 .41 .31 .25 .15
ATP .94 .88 1.17 .89 .99 1.36 .91
KLA/ATP .51 .54 .67 .52 .61 .74 .48
Itgb4
KLA  ATP  ATP+KLA
 AK048888 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230078O20 product:integrin beta 4, full insert sequence. [AK048888] KLA .98 .92 .98 1.08 .97 1.02 1.02
ATP .99 .99 .91 1.03 1.02 1.00 1.05
KLA/ATP .99 1.03 .99 .98 .94 .98 1.01
Itgb4
KLA  ATP  ATP+KLA
 NM_001005608 integrin beta 4 (Itgb4), transcript variant 1, mRNA [NM_001005608] KLA 1.09 1.11 1.12 1.08 .98 .86 .85
ATP .90 .89 .90 .95 .87 .87 .84
KLA/ATP 1.06 1.08 1.10 1.18 1.07 .90 .76
Itgb5
KLA  ATP  ATP+KLA
 NM_010580 integrin beta 5 (Itgb5), mRNA [NM_010580] KLA .72 .68 .67 .66 .54 .43 .36
ATP 1.09 .94 .78 .57 .63 .56 .62
KLA/ATP .78 .64 .67 .51 .64 .67 .38
Itgb6
KLA  ATP  ATP+KLA
 NM_021359 integrin beta 6 (Itgb6), mRNA [NM_021359] KLA .97 1.02 1.04 1.06 1.06 1.04 1.01
ATP .99 1.00 1.01 .96 1.04 1.00 1.00
KLA/ATP .99 1.03 1.08 1.02 1.02 1.03 1.01
Itgb7
KLA  ATP  ATP+KLA
 NM_013566 integrin beta 7 (Itgb7), mRNA [NM_013566] KLA .91 .88 .93 1.19 .93 .76 .79
ATP 1.00 .96 1.30 1.44 2.84 3.07 7.90
KLA/ATP .96 1.05 1.35 1.20 2.70 3.53 8.17
Itgb8
KLA  ATP  ATP+KLA
 AK029281 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832412O06 product:SIMILAR TO INTEGRIN, BETA 8 homolog [Homo sapiens], full insert sequence. [AK029281] KLA 4.66 5.00 3.59 2.70 1.76 1.34 1.32
ATP 1.01 .98 1.09 1.16 2.15 5.24 1.17
KLA/ATP 5.59 6.39 4.38 1.99 1.84 2.55 2.11
Itgb8
KLA  ATP  ATP+KLA
 AK034644 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430018C17 product:integrin beta 8, full insert sequence. [AK034644] KLA 1.18 1.02 1.04 1.03 1.05 .94 .93
ATP .96 .97 .97 .96 .90 1.04 .99
KLA/ATP 1.06 1.06 1.15 .92 .99 1.00 1.09
Itgb8
KLA  ATP  ATP+KLA
 AK140969 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130086L01 product:hypothetical protein, full insert sequence [AK140969] KLA 3.63 3.76 4.16 3.31 2.72 1.58 1.40
ATP .98 1.01 1.31 1.14 1.28 6.11 1.65
KLA/ATP 3.84 4.18 3.75 2.83 1.92 3.44 4.81
Jup
KLA  ATP  ATP+KLA
 NM_010593 junction plakoglobin (Jup), mRNA [NM_010593] KLA .96 .98 .98 .88 .99 1.26 .77
ATP .99 1.08 .99 .99 .98 1.06 .82
KLA/ATP .96 .92 .92 .93 1.00 1.49 .80
Lama2
KLA  ATP  ATP+KLA
 AK046114 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230342M05 product:laminin, alpha 2, full insert sequence. [AK046114] KLA 1.06 1.00 .95 1.10 1.04 .99 .96
ATP .98 1.09 1.00 .97 .96 1.12 1.01
KLA/ATP .94 1.04 1.05 1.00 .99 1.00 .98
Lama2
KLA  ATP  ATP+KLA
 NM_008481 laminin, alpha 2 (Lama2), mRNA [NM_008481] KLA .96 .99 .96 1.02 .95 1.00 .97
ATP 1.05 1.00 1.01 .94 1.01 1.04 .96
KLA/ATP .99 1.04 1.06 1.10 .98 .95 .97
Lama2
KLA  ATP  ATP+KLA
 U12147 laminin-2 alpha2 chain mRNA, complete cds. [U12147] KLA .96 1.00 .99 1.00 .98 1.02 1.03
ATP 1.01 .99 1.02 1.04 1.01 .99 1.02
KLA/ATP 1.00 1.01 1.00 1.01 .99 1.04 1.00
Lef1
KLA  ATP  ATP+KLA
 NM_010703 lymphoid enhancer binding factor 1 (Lef1), mRNA [NM_010703] KLA 1.00 1.05 1.00 1.05 1.01 1.07 1.07
ATP .96 .98 1.03 1.09 .99 1.04 1.00
KLA/ATP 1.02 .98 .95 1.08 1.02 1.16 1.08
Lmna
KLA  ATP  ATP+KLA
 NM_019390 lamin A (Lmna), transcript variant 2, mRNA [NM_019390] KLA .86 .86 .78 .66 .47 .27 .37
ATP .99 1.01 1.03 1.23 1.27 1.13 1.61
KLA/ATP .89 .86 .80 .86 .99 .86 1.14
LOC10004
4500
KLA  ATP  ATP+KLA
 XM_001472229 ref|PREDICTED: Mus musculus similar to Dsg2 protein (LOC100044500), mRNA [XM_001472229] KLA 1.01 .96 1.00 1.01 .97 .97 1.07
ATP 1.04 .93 1.00 1.03 1.01 .95 1.00
KLA/ATP 1.00 .99 .94 .93 1.03 1.01 .98
Mm.21499
4
KLA  ATP  ATP+KLA
 148540002 Unknown KLA 1.04 1.08 1.14 1.05 1.07 1.18 1.23
ATP 1.02 .99 1.08 1.05 1.00 1.01 1.01
KLA/ATP 1.02 1.11 1.10 .99 1.03 1.10 1.11
Mm.25743
7
KLA  ATP  ATP+KLA
 161760626 Unknown KLA 1.00 1.03 1.07 1.00 .95 1.08 1.06
ATP 1.00 1.14 1.03 .99 1.05 1.03 1.02
KLA/ATP 1.03 1.04 1.00 1.01 1.04 1.00 1.01
Mm.27604
2
KLA  ATP  ATP+KLA
 18702319 Unknown KLA .81 .72 .70 .70 .54 .54 .67
ATP .90 .95 1.17 1.15 1.35 1.32 1.13
KLA/ATP .70 .78 .89 .83 1.09 1.13 .97
Mm.35799
0
KLA  ATP  ATP+KLA
 21687185 Unknown KLA 1.18 1.20 1.19 1.23 1.18 1.19 1.10
ATP .97 1.07 1.11 1.19 1.01 1.15 .98
KLA/ATP 1.06 1.29 1.19 1.29 1.19 1.10 1.10
Mm.44077
3
KLA  ATP  ATP+KLA
 124517717 Unknown KLA .69 .69 .71 .76 .71 .73 .58
ATP .93 .96 1.01 .85 .73 .76 .57
KLA/ATP .60 .65 .75 .80 .76 .66 .55
Mm.44591
2
KLA  ATP  ATP+KLA
 9506452 Unknown KLA .98 .99 1.00 1.07 .99 .98 1.07
ATP 1.02 1.05 .94 .96 1.01 1.00 .94
KLA/ATP 1.01 1.08 1.04 .92 .92 1.00 1.03
Mm.45680
7
KLA  ATP  ATP+KLA
 157951728 Unknown KLA 1.00 1.02 1.05 .97 .99 .96 1.05
ATP 1.13 .98 1.00 1.06 1.02 .94 .98
KLA/ATP 1.11 .96 1.08 1.01 .99 1.01 .98
Mm.46359
0
KLA  ATP  ATP+KLA
 21687181 Unknown KLA .76 .80 .87 .99 .94 1.02 .98
ATP .90 .94 1.06 .97 .83 .93 .85
KLA/ATP .79 .91 .98 1.01 .97 .84 .78
Mm.87663
KLA  ATP  ATP+KLA
 142370454 Unknown KLA 1.04 1.01 1.01 1.10 .95 1.04 .95
ATP .96 1.01 .96 .98 .94 1.05 1.12
KLA/ATP .98 .97 1.12 1.03 1.06 .94 1.02
Pkp2
KLA  ATP  ATP+KLA
 NM_026163 plakophilin 2 (Pkp2), mRNA [NM_026163] KLA .90 .87 .87 .83 .70 .69 .67
ATP .93 .94 1.28 1.21 1.89 3.21 2.22
KLA/ATP .93 .93 .96 1.02 1.08 1.51 1.14
Ryr2
KLA  ATP  ATP+KLA
 BC043140 ryanodine receptor 2, cardiac, mRNA (cDNA clone IMAGE:6822493), complete cds. [BC043140] KLA .97 1.03 1.01 1.03 1.03 1.01 1.05
ATP .99 .98 1.03 1.02 1.01 1.09 1.04
KLA/ATP .98 1.00 .98 1.04 1.04 1.06 1.00
Ryr2
KLA  ATP  ATP+KLA
 NM_023868 ryanodine receptor 2, cardiac (Ryr2), mRNA [NM_023868] KLA 1.04 1.02 1.00 1.00 1.03 .97 .96
ATP .95 1.04 1.00 .94 .98 1.01 1.08
KLA/ATP .99 .97 1.02 1.03 1.00 .98 1.00
Sgca
KLA  ATP  ATP+KLA
 NM_009161 sarcoglycan, alpha (dystrophin-associated glycoprotein) (Sgca), mRNA [NM_009161] KLA .96 1.06 1.08 1.01 1.06 1.10 1.08
ATP 1.00 .99 1.04 1.04 1.06 .90 1.05
KLA/ATP .98 .96 1.06 1.03 1.18 1.17 1.11
Sgcb
KLA  ATP  ATP+KLA
 AK009080 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310001O14 product:unclassifiable, full insert sequence. [AK009080] KLA 1.32 1.24 1.20 1.23 1.10 1.06 .97
ATP .93 .85 .88 .89 .94 .93 1.01
KLA/ATP 1.19 1.13 .98 .92 1.03 1.04 .97
Sgcb
KLA  ATP  ATP+KLA
 NM_011890 sarcoglycan, beta (dystrophin-associated glycoprotein) (Sgcb), mRNA [NM_011890] KLA 2.98 2.85 3.65 3.67 3.43 2.59 1.47
ATP 1.15 1.07 1.28 1.20 1.19 1.03 1.42
KLA/ATP 2.87 3.08 3.92 3.05 2.71 2.38 1.91
Sgcd
KLA  ATP  ATP+KLA
 NM_011891 sarcoglycan, delta (dystrophin-associated glycoprotein) (Sgcd), mRNA [NM_011891] KLA 1.08 1.07 1.01 1.01 1.07 .96 .93
ATP 1.00 .95 1.03 1.08 1.00 .98 1.01
KLA/ATP .97 .97 1.08 1.03 .95 1.01 1.03
Sgcg
KLA  ATP  ATP+KLA
 NM_011892 sarcoglycan, gamma (dystrophin-associated glycoprotein) (Sgcg), mRNA [NM_011892] KLA .94 .94 1.05 1.06 1.00 1.02 .98
ATP 1.02 .98 1.19 1.08 1.10 1.14 .90
KLA/ATP 1.02 1.06 1.09 1.22 1.13 1.08 .82
Slc8a1
KLA  ATP  ATP+KLA
 AF004666 sodium-calcium exchanger (NCX1) mRNA, complete cds. [AF004666] KLA 1.13 1.10 1.22 1.44 1.52 1.55 1.10
ATP 1.03 1.05 1.22 1.12 .65 .49 .67
KLA/ATP 1.04 1.21 1.30 1.44 .81 .63 1.01
Slc8a1
KLA  ATP  ATP+KLA
 AF108396 sodium/calcium exchanger isoform NaCa3 (Ncx1) mRNA, partial cds. [AF108396] KLA 1.07 1.18 1.30 1.22 1.31 1.39 1.21
ATP 1.03 1.02 1.10 1.07 .88 .91 1.23
KLA/ATP 1.15 1.17 1.14 1.22 .96 1.01 1.77
Slc8a1
KLA  ATP  ATP+KLA
 NM_011406 solute carrier family 8 (sodium/calcium exchanger), member 1 (Slc8a1), transcript variant A, mRNA [NM_011406] KLA 1.12 1.16 1.22 1.25 1.35 1.33 1.11
ATP 1.03 1.04 1.07 1.10 .93 .90 1.19
KLA/ATP 1.13 1.24 1.19 1.16 .93 1.06 1.62
Tcf3
KLA  ATP  ATP+KLA
 NM_001079822 transcription factor 3 (Tcf3), transcript variant 1, mRNA [NM_001079822] KLA 1.03 .98 1.01 .98 .98 1.03 1.01
ATP 1.00 1.02 1.00 1.06 1.10 1.07 .99
KLA/ATP 1.07 .99 .97 1.05 1.05 1.11 .96
Tcf7
KLA  ATP  ATP+KLA
 NM_009331 transcription factor 7, T-cell specific (Tcf7), mRNA [NM_009331] KLA 1.00 1.01 1.03 1.00 .98 1.01 1.07
ATP .99 .98 1.02 1.03 1.03 1.00 1.01
KLA/ATP 1.00 1.03 1.04 1.02 1.04 1.02 1.00
Tcf7l2
KLA  ATP  ATP+KLA
 NM_009333 transcription factor 7-like 2, T-cell specific, HMG-box (Tcf7l2), mRNA [NM_009333] KLA 1.01 1.12 1.11 1.31 1.06 1.34 1.29
ATP 1.04 1.05 .94 1.06 .90 .81 .96
KLA/ATP 1.08 1.11 1.05 1.18 1.04 1.02 1.42